Carter's Q3 10-Q: $36.6M Net Income, 47.1% Gross Margin, New C-Suite Appointments
CRI sits 15% above its 52-week low of $27.86 on light trading volume (0.4× avg).
Summary
Carter's third-quarter 10-Q confirms $752.5M in sales, 47.1% gross margin and $1.00 diluted EPS, and discloses a sweeping new executive team under CEO Sharon Price John.
Key Events · Earnings and Guidance · CRI
-
Q3 Sales Flat, Margins Expand
Net sales slipped 0.7% to $752.5M, but gross margin rose 200 bps to 47.1% on higher average unit retail and favorable channel mix.
-
Operating Income Nearly Doubles
Operating income climbed 91.7% to $55.8M and diluted EPS jumped to $1.00 from $0.32, helped by a $13.8M SG&A reduction and the absence of last year's $8.8M pension settlement charge.
-
Tariff Refund Flatters Nine-Month Results
Nine-month gross profit includes a $127.7M IEEPA tariff refund recovery in cost of goods sold plus $4M of interest income; roughly $2M of claims remain unadjudicated and unrecognized.
-
New Executive Team Disclosed
Four new C-level appointments were announced October 30, 2026, a standalone COO search began with CFO Richard Westenberger stepping down as COO, and Chief Sales Officer Julie D'Emilio retired that day.
Analysis · CRI · Manufacturing
Hard numbers now sit behind this morning's Q3 beat. Net sales came in at $752.5M, down 0.7%, while gross margin expanded 200 bps to 47.1%; operating income rose 91.7% to $55.8M and diluted EPS reached $1.00 versus $0.32 a year ago. The nine-month picture is flattered by the $127.7M IEEPA tariff refund booked in cost of goods sold, so the underlying operating improvement — SG&A down 4.3% and segment operating income up 26.3% — is the part that carries into next year. Alongside the numbers, the filing discloses a broad leadership build-out under new CEO Sharon Price John: four new C-level roles, a COO search, and two retirements. That is the first real look at her operating team and the cost base that goes with it.
How filings like this one have moved
In the 30 days to Nov 12, 2026, 37% of the 3595 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CRI was trading at $32.14 on NYSE in the Manufacturing sector, with a market capitalization of approximately $1.2B. The 52-week trading range was $27.86 to $44.44. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.